OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Retinal and Eye Research is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
The neuroimmune interface in retinal regeneration	275
In vivo application of base and prime editing to treat inherited retinal diseases	169
Widefield OCT angiography	150
Cell identity changes in ocular surface Epithelia	149
Phenotyping and genotyping FEVR: Molecular genetics, clinical and imaging features, and therapeutics	148
Animal models for the evaluation of retinal stem cell therapies	126
Non-vasogenic cystoid maculopathies	121
International consensuses and controversies on causes, diagnosis and management of diabetic macular edema (DME)	113
Editorial Board	112
Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens	110
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration	108
Central serous chorioretinopathy: An evidence-based treatment guideline	107
Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives	106
Unravelling CYP4V2: Clinical features, genetic insights, pathogenic mechanisms and therapeutic strategies in Bietti crystalline corneoretinal dystrophy	101
Corneal stromal repair and regeneration	99
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	90
Editorial Board	85
Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors	83
Homeostatic plasticity in the retina	83
A paradigm shift in retinal detachment repair: The concept of integrity	82
Squishy matters – Corneal mechanobiology in health and disease	79
Myocilin misfolding and glaucoma: A 20-year update	78
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)	76
Cell fate decisions, transcription factors and signaling during early retinal development	74
Risk factors, clinical features and treatment of Behçet's disease uveitis	74

The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease	73
RNA-targeting strategies as a platform for ocular gene therapy	72
Femtosecond lasers in ophthalmology: Mechanisms, clinical breakthroughs, and multidisciplinary frontiers	72
Editorial Board	71
Protection against corneal hyperosmolarity with soft-contact-lens wear	71
Genetic architecture of congenital cataracts: correlation of pathogenic variants with morphology and clinical outcomes	68
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration	68
The retinal pigmentation pathway in human albinism: Not so black and white	66
How gut microbiota may impact ocular surface homeostasis and related disorders	66
Approaches for corneal endothelium regenerative medicine	64
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220]	63
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy	63
Rhodopsin, light-sensor of vision	61
Cellular component transfer between photoreceptor cells of the retina	60
Optical coherence tomography angiography in diabetic retinopathy	58
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives	57
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence	56
Editorial Board	53
Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies	52
Pentosan polysulfate maculopathy: clinical considerations, pathobiology, and causality	52
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation	51
Interventions to reduce incidence and progression of myopia in children and adults	50
Beyond convolutions and supervised learning with transformers and representation learning for retinal image analysis	50
Retinal pigment epithelium 65 kDa protein (RPE65): An update	50
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye	48
Regulation of lens water content: Effects on the physiological optics of the lens	47
Editorial Board	46
The march to harmonized imaging standards for retinal imaging	44
Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma	43
Quantitative analysis of conjunctival vascular alterations: Applications in ocular and systemic disease detection	43
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)	43
Quantitative approaches in multimodal fundus imaging: State of the art and future perspectives	43
Bacterial keratitis: identifying the areas of clinical uncertainty	42
Retinal TRP channels: Cell-type-specific regulators of retinal homeostasis and multimodal integration	42
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity	42
The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health	41
Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases	40
Clinical histopathology and pathogenesis of macular telangiectasia type 2	39
The ocular surface in type 2 diabetes: pathophysiology and impact of anti-diabetic drugs	38
The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies	38